Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01373177 · ClinicalTrials.gov registry record · NA
Differences Between the Bayley-II and the Bayley-III in Very Preterm Infants at 2 Years
A NA study of Infant Development, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- NA
- Development phase
- 119
- Enrollment target
- 1
- Study location
NCT01373177: Completed NA study of Infant Development, sponsored by Children's Hospital of Philadelphia.
NCT01373177 is a NA study of Infant Development that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 119 participants, below the 399-participant average among 30 other Infant Development trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01373177, a NA study of Infant Development, has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- NA
- Development phase
- 119 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this randomized study is to test the hypothesis that scores on the Bayley Scales of Infant Development-III (Bayley-III) are higher than scores on the Bayley Scales of Infant Development-II (BSID-II) in the same group of infants who were born very preterm.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Bayley Scales of Infant Development-II
- DIAGNOSTIC_TEST Bayley Scales of Infant Development-III
Study Locations (1)
Pennsylvania
- The Children's Hospital of Philadelphia - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 119 participants |
| Start Date | 2011-01 |
| Est. Completion | 2015-02 |
| Phase | NA |
What the finished NCT01373177 record still lists
NCT01373177 is an interventional study that assigns participants to a tested intervention. The registered 119 participants enrollment target is mid-sized for trials with a published cap, below the 399-participant average among 30 other Infant Development trials with a reported enrollment target (70% lower).
The record links to 1 condition, with Infant Development appearing as the primary indexed condition, and to 2 interventions - of which Bayley Scales of Infant Development-II is the first listed.
NCT01373177 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01373177 about?
NCT01373177 is a clinical study titled "Differences Between the Bayley-II and the Bayley-III in Very Preterm Infants at 2 Years". The objective of this randomized study is to test the hypothesis that scores on the Bayley Scales of Infant Development-III (Bayley-III) are higher than scores on the Bayley Scales of Infant Development-II (BSID-II) in the same group of infants who were born very preterm.
What is the current status of trial NCT01373177?
This trial is currently completed. It is a NA study. The enrollment target is 119 participants. The study started on 2011-01. Estimated completion is 2015-02.
What conditions does trial NCT01373177 study?
This clinical trial studies the following conditions: Infant Development.
What interventions are being tested in trial NCT01373177?
The interventions under investigation include: Bayley Scales of Infant Development-II (DIAGNOSTIC_TEST), Bayley Scales of Infant Development-III (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT01373177?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01373177 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Infant Development
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01373177's enrollment target sits among peer trials
119 16th of 30 higher than 15 of 30 other Infant Development trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Infant Development trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Walnuts as an Infant Solid Food for Health
RECRUITING · NA
-
Infant-Maternal Partnership and Cognitive Training Study for Preterm Infants
RECRUITING · NA
-
The Impact of Music Medicine on Preterm Brain Development and Behavior
RECRUITING · NA
-
Intervening With Opioid-Dependent MothersMothers and Infants
RECRUITING · NA
-
Investigating Baby Behavior and Family Technology Use Study
RECRUITING · NA
-
Investigating Fit and Satisfaction of the Prone Positioner
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04870762 · 119 participants · Phase 2
Customized 3D Printed Oral Stents During Head and Neck Radiotherapy
- NCT05559853 · 119 participants
Developing a New MRI Technique to Understand Changes in Brain Tumors After Treatment
- NCT06564389 · 119 participants · Phase 1
FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients
- NCT06742801 · 119 participants · NA
Onyx™ Liquid Embolic IDE Clinical Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia